: The Department proposes to repeal the rule after a comprehensive review determined that the rule is no longer necessary in accordance with Section 120.745, F.S. The rule has previously been incorporated into law and its repeal will have no ...
RULE NO.: RULE TITLE:
2-40.006: Addition of Alphamethyltryptamine (AMT) to Schedule I, Subsection 893.03(1), F.SPURPOSE AND EFFECT: The Department proposes to repeal the rule after a comprehensive review determined that the rule is no longer necessary in accordance with Section 120.745, F.S. The rule has previously been incorporated into law and its repeal will have no practical effect.
SUMMARY: The rule amendment will repeal the rule after a comprehensive review determined that the rule is no longer necessary in accordance with Section 120.745, F.S.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COST: During discussion of the economic impact of this rule the Department, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Cost (SERC) was not necessary and that these rule amendments will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time. The rule will not have an adverse impact on small business, or likely increase regulatory costs in excess of $200,000 in the aggregate within 1 year after implementation of the rule.
Any person who wishes to provide information regarding the statement of estimated costs, or to provide a proposal for a lower regulatory cost alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 893.035 FS.
LAW IMPLEMENTED: 893.035 FS.IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE ANNOUNCED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Ed Tellechea, Chief Assistant Attorney General-DLA, PL-01, The Capitol, Bin #4100, 107 West Gaines Street, Tallahassee, Florida 32399
THE FULL TEXT OF THE PROPOSED RULE IS:
2-40.006 Addition of Alphamethyltryptamine (AMT) to Schedule I, Subsection 893.03(1), F.S.
Rulemaking Specific Authority 893.035 FS. Law Implemented 893.035 FS. History–New 1-12-03, Repealed________.
NAME OF PERSON ORIGINATING PROPOSED RULE: Ed Tellechea, Chief Assistant Attorney General-DLA
NAME OF SUPERVISOR OR PERSON WHO APPROVED THE PROPOSED RULE: Pam Bondi, Attorney General
DATE PROPOSED RULE APPROVED BY AGENCY HEAD: November 17, 2011
Document Information
- Comments Open:
- 12/2/2011
- Summary:
- The rule amendment will repeal the rule after a comprehensive review determined that the rule is no longer necessary in accordance with Section 120.745, F.S.
- Purpose:
- : The Department proposes to repeal the rule after a comprehensive review determined that the rule is no longer necessary in accordance with Section 120.745, F.S. The rule has previously been incorporated into law and its repeal will have no practical effect.
- Rulemaking Authority:
- 893.035 FS.
- Law:
- 893.035 FS.
- Contact:
- Ed Tellechea, Chief Assistant Attorney General-DLA, PL-01, The Capitol, Bin #4100, 107 West Gaines Street, Tallahassee, Florida 32399
- Related Rules: (1)
- 2-40.006. Addition of Alphamethyltryptamine (AMT) to Schedule I, Subsection 893.03(1), F.S